Notch signaling promotes bone marrow-induced drug resistance in multiple myeloma through the regulation of the CXCR4/CXCL12 system
M. Colombo(Human Technopole), Raffaella Chiaramonte(University of Milan), Antonino Neri(University of Milan), Anna Pistocchi(University of Milan), Andrea Basile(University of Milan), Mara Mazzola(University of Milan), G. Domenica, Elisa Lazzari(University of Trieste), Maria Teresa Palano(University of Milan), M. Alejandro Barbieri(Florida International University), Natalia Platonova(University of Milan), S. Garavelli(University of Milan)
Unknown
September 20, 2018
Cited by 0
Related Papers
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
|Blood|2015|216
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma
|Nature Communications|2017|142
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
|Blood|2020|139
Autoimmune cytopenias in chronic lymphocytic leukemia
|American Journal of Hematology|2014|119